» Articles » PMID: 35723622

A Retrospective Cohort Study: Pre-operative Oral Enteral Nutritional Optimisation for Crohn's Disease in a UK Tertiary IBD Centre

Abstract

Background: Low-quality evidence suggests that pre-operative exclusive enteral nutrition (E/EN) can improve postoperative outcomes in patients with Crohn's disease (CD). It is not standard practice in most centres.

Aims: To test the hypothesis that pre-operative EN in patients undergoing ileal/ileocolonic surgery for CD is associated with improved postoperative outcome.

Methods: We performed a single centre retrospective observational study comparing surgical outcomes in patients receiving pre-operative EN (≥600 kcal/day for ≥2 weeks) with those who received no nutritional optimisation. Consecutive adult patients undergoing ileal/ileocolonic resection from 2008 to 2020 were included. The primary outcome was postoperative complications <30 days. Secondary outcomes included EN tolerance, specific surgical complications, unplanned stoma formation, length of stay, length of bowel resected, readmission and biochemical/anthropometric changes.

Results: 300 surgeries were included comprising 96 without nutritional optimisation and 204 optimised cases: oral EN n = 173, additional PN n = 31 (4 of whom had received nasogastric/nasojejunal EN). 142/204 (69.6%) tolerated EN. 125/204 (61.3%) initiated EN in clinic. Patients in the optimised cohort were younger at operation and diagnosis, with an increased frequency of penetrating disease and exposure to antibiotics or biologics, and were more likely to undergo laparoscopic surgery. The optimised cohort had favourable outcomes on multivariate analysis: all complications [OR 0.29; 0.15-0.57, p < 0.001], surgical complications [OR 0.41; 95% CI 0.20-0.87, p = 0.02], non-surgical complications [OR 0.24 95% CI 0.11-0.52, p < 0.001], infective complications [OR 0.32; 95% CI 0.16-0.66, p = 0.001].

Conclusions: Oral EN was reasonably well tolerated and associated with a reduction in 30-day postoperative complications. Randomised controlled trials are required to confirm these findings.

Citing Articles

Machine learning for temporary stoma after intestinal resection in surgical decision-making of Crohn's disease.

Wang F, Lin Y, Gao R, Wu X, Wu T, Jiao Y BMC Gastroenterol. 2025; 25(1):117.

PMID: 40000985 PMC: 11863836. DOI: 10.1186/s12876-025-03668-7.


Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options.

Diez-Martin E, Hernandez-Suarez L, Munoz-Villafranca C, Martin-Souto L, Astigarraga E, Ramirez-Garcia A Int J Mol Sci. 2024; 25(13).

PMID: 39000169 PMC: 11241012. DOI: 10.3390/ijms25137062.


Preoperative Crohn's Disease Exclusion Diet and Exclusive Enteral Nutrition in Adults with Crohn's Disease: A Feasibility Randomised Controlled Trial.

Wall C, Bensley R, Glyn T, Haines M, Rowbotham D, Bissett I Nutrients. 2024; 16(13).

PMID: 38999853 PMC: 11243368. DOI: 10.3390/nu16132105.


Multimodal Prehabilitation for Patients with Crohn's Disease Scheduled for Major Surgery: A Narrative Review.

Fiorindi C, Giudici F, Testa G, Foti L, Romanazzo S, Tognozzi C Nutrients. 2024; 16(11).

PMID: 38892714 PMC: 11174506. DOI: 10.3390/nu16111783.


Predicting short-term major postoperative complications in intestinal resection for Crohn's disease: A machine learning-based study.

Wang F, Lin Y, Yuan X, Gao R, Wu X, Xu W World J Gastrointest Surg. 2024; 16(3):717-730.

PMID: 38577067 PMC: 10989335. DOI: 10.4240/wjgs.v16.i3.717.


References
1.
Meade S, Patel K, Luber R, OHanlon D, Caracostea A, Pavlidis P . A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre. Aliment Pharmacol Ther. 2022; 56(4):646-663. PMC: 9544188. DOI: 10.1111/apt.17055. View

2.
Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hebuterne X, Abitbol V . Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut. 2017; 67(1):53-60. PMC: 5754855. DOI: 10.1136/gutjnl-2016-312581. View

3.
Donnellan C, Yann L, Lal S . Nutritional management of Crohn's disease. Therap Adv Gastroenterol. 2013; 6(3):231-42. PMC: 3625021. DOI: 10.1177/1756283X13477715. View

4.
Alsaleh A, Gaidos J, Kang L, Kuemmerle J . Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Dig Dis Sci. 2016; 61(9):2602-7. PMC: 4982818. DOI: 10.1007/s10620-016-4171-9. View

5.
De Cruz P, Kamm M, Hamilton A, Ritchie K, Krejany E, Gorelik A . Crohn's disease management after intestinal resection: a randomised trial. Lancet. 2014; 385(9976):1406-17. DOI: 10.1016/S0140-6736(14)61908-5. View